The purpose of the program. Formulation of new treatments for heart and pulmonary failure through using organ-replacing technologies. Formulation of a clinical protocol and implementation of treatment methods into clinical practice heart and pulmonary failure using organ-replacing technologies. New methods were created for rehabilitating the function of affected organs after implantation of the LVAD, a total artificial heart, an extracorporeal life-sustaining system will be of great importance, both for Kazakhstan and for states with similar problems of donor organ deficiency, will also improve the effectiveness of surgical treatment and reduce the level of complications and mortality of patients on the extracorporeal life-sustaining system and septic patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Extracorporeal life support system with pulmonary and / or heart failure: Cytokine response
Timeframe: 24-48 hours
Extracorporeal life support system with pulmonary and / or heart failure: SOFA-Score
Timeframe: 24, 48, 72 hours
Extracorporeal life support system with pulmonary and / or heart failure
Timeframe: Time: first 72 hours
Patients with left ventricular assist device implantation: Difference of Cytokine response
Timeframe: 24-48 hours
Patients with left ventricular assist device implantation:vasopressors and / or inotropes
Timeframe: first 72 hours
Patients with left ventricular assist device implantation:Renal function
Timeframe: first 72 hours
Patients with left ventricular assist device implantation:Lactate level
Timeframe: first 72 hours
For operations with prolonged artificial circulation, hypothermia and circulatory arrest: Difference of Cytokine response
Timeframe: 24-48 hours
For operations with prolonged artificial circulation, hypothermia and circulatory arrest: SOFA-Score
Timeframe: 24, 48, 72 hours
Extracorporeal life support system with pulmonary and / or heart failure:Difference of mean arterial pressure
Timeframe: 24, 48, 72 hours
Extracorporeal life support system with pulmonary and / or heart failure: Difference of CVP
Timeframe: 24, 48, 72 hours
Extracorporeal life support system with pulmonary and / or heart failure: Serum lactate
Timeframe: 24, 48, 72 hours
Extracorporeal life support system with pulmonary and / or heart failure:Days on ventilator, vasopressor and renal replacement therapy
Timeframe: until day 30 post-surgery
For operations with prolonged artificial circulation, hypothermia and circulatory arrest: Difference of mean arterial pressure
Timeframe: 24, 48, 72 hours
For operations with prolonged artificial circulation, hypothermia and circulatory arrest: Difference of CVP
Timeframe: 24, 48, 72 hours
For operations with prolonged artificial circulation, hypothermia and circulatory arrest: Level of Serum lactate
Timeframe: 24, 48, 72 hours